MBrace Therapeutics
MBrace Therapeutics is a United States-based biotechnology company running 2 late-stage cancer trials in prostate cancer, HR-positive / HER2-negative breast cancer and colorectal cancer.
Overview
MBrace Therapeutics, based in San Diego, CA, the United States, is a biotechnology company. MBrace Therapeutics is a clinical-stage biopharmaceutical company developing antibody-drug conjugates (ADCs) for cancer, using a proprietary in vivo target-discovery platform called SPARTA. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials in prostate cancer, HR-positive / HER2-negative breast cancer, colorectal cancer, non-small-cell lung cancer and pancreatic ductal adenocarcinoma. The largest, NCT07145255 (Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumours), plans to enrol 150 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Similar pages
not linked directly; found by shared links- CompanyShenzhen Ionova Life Sciences
Shares Pancreatic ductal adenocarcinoma, Prostate cancer, Colorectal cancer, HR-positive / HER2-negative breast cancer and the tag ctgov-sponsor.
- CompanyOrion, Orion Pharma
Shares Pancreatic ductal adenocarcinoma, Prostate cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyOncolytics Biotech
Shares Pancreatic ductal adenocarcinoma, Colorectal cancer, HR-positive / HER2-negative breast cancer and the tag ctgov-sponsor.
- CompanyCivaTech Oncology
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanySTCube
Shares Colorectal cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyMultitude Therapeutics
Shares Colorectal cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyNuvation Bio
Shares Pancreatic ductal adenocarcinoma, Prostate cancer, HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyMolecular Partners
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag ctgov-sponsor.